On 2 October 2026, Hemostasis Today featured a LinkedIn post by Archil Jaliashvili in its Voices section, exploring BHOC as a complementary oxygen-delivery strategy in postpartum hemorrhage.
The post begins with the priority of controlling bleeding. It then asks how effective tissue oxygen delivery might be supported when severe blood loss develops and definitive care or donor blood is still unavailable.
Archil describes BHOC (Biological Hemoglobin Oxygen Carrier) as a potential oxygen-delivery bridge in this research context, alongside hemorrhage control and transfusion. This is a research perspective within Precision Oxygen Therapeutics.
The proposed role of BHOC in postpartum hemorrhage remains a research hypothesis, not an approved PPH treatment. Read the BHOC postpartum hemorrhage research context.
Original publication and attribution
Archil Jaliashvili: Exploring BHOC as a Complementary Oxygen-Delivery Strategy
Hemostasis Today, Voices. Published 2 October 2026.
- Original post author
- Archil Jaliashvili. Read the original LinkedIn post ↗
- Coverage
- Hemostasis Today. The article does not name an individual journalist.
- Photograph
- Archil Jaliashvili / LinkedIn, as credited by Hemostasis Today.